second asia-pacific regional meeting for national …€¦ · for member states in the south-east...
TRANSCRIPT
Meeting Report
22–23 October 2019Wellington, New Zealand
SECOND ASIA-PACIFIC REGIONAL MEETING FOR NATIONAL ETHICS/BIOETHICS
COMMITTEES
WORLD HEALTH ORGANIZATION
REGIONAL OFFICE FOR THE WESTERN PACIFIC
RS/2019/GE/39(NEZ) English only
MEETING REPORT
SECOND ASIA-PACIFIC REGIONAL MEETING FOR NATIONAL
ETHICS/BIOETHICS COMMITTEES
Convened by:
WORLD HEALTH ORGANIZATION
In collaboration with:
UNITED NATIONS EDUCATION, SCIENTIFIC AND CULTURAL
ORGANIZATION; AND KĀHUI MATATIKA O TE MOTU - NEW ZEALAND
NATIONAL ETHICS ADVISORY COMMITTEE
Wellington, New Zealand
22 – 23 October 2019
Not for sale
Printed and distributed by:
World Health Organization
Regional Office for the Western Pacific
Manila, Philippines
December 2019
2
NOTE
The views expressed in this report are those of the participants of the Second Asia-Pacific
Regional Meeting for National Ethics/Bioethics Committees and do not necessarily reflect the
policies of the conveners.
This report has been prepared by the World Health Organization Regional Office for the Western Pacific
for Member States in the South-East Asia and Western Pacific Regions and for those who participated
in the Second Asia-Pacific Regional Meeting for National Ethics/Bioethics Committees in Wellington,
New Zealand, from 22 to 23 October 2019.
3
CONTENTS
SUMMARY ............................................................................................................................................ 4
1. INTRODUCTION .............................................................................................................................. 5
1.1 Meeting organization ..................................................................................................................... 5
1.2 Meeting objectives ........................................................................................................................ 5
2. PROCEEDINGS ................................................................................................................................. 6
2.1 Opening session ............................................................................................................................. 6
2.2 Technical Sessions ........................................................................................................................ 6
3. CONCLUSIONS AND RECOMMENDATIONS ........................................................................... 14
3.1 Conclusions ................................................................................................................................. 14
3.2 Recommendations ....................................................................................................................... 14
3.2.1 Recommendations for Member States .................................................................................. 14
3.2.2 Recommendations for WHO ................................................................................................ 15
ANNEXES ............................................................................................................................................ 16
Annex 1. List of participants
Annex 2. Meeting programme
Annex 3. Summary of Conclusions from Group Work
Annex 4. Session 5: Ways Forward – Country Worksheets
Keywords: Bioethics / Education, Public health professional – ethics / Regional health planning
4
SUMMARY
The Second Asia-Pacific Regional Meeting for National Ethics/Bioethics Committees (AP-NEC2)
was organized to support Member States in strengthening their health ethics frameworks, including
through the development of National Ethics/Bioethics Committees (NECs). AP-NEC2 was chaired by
Kāhui Matatika o te Motu - the National Ethics Advisory Committee of New Zealand (NEAC), with
support from the World Health Organization (WHO) in collaboration with the United Nations
Educational, Scientific and Cultural Organization (UNESCO). The meeting was attended by 34
delegates from 22 countries, including 18 from the Western Pacific Region and five from the South-
East Asia Region.
The theme for AP-NEC2 was reducing inequities through solutions-orientated bioethics. Health
equity is a concept based on the ethical notion of distributive justice. Pursuing health equity means
minimizing inequalities in health and in the key determinants of health. Key determinants of health
include modifiable social and physical conditions as well as medical-based care; both need to be
addressed to achieve health equity. Health equity issues were considered at AP-NEC2 in the context
of three technical topics: climate change, emerging technologies and indigenous populations; and
discussed through the three streams of health ethics: public health ethics, clinical care ethics, and
health research ethics.
Participants agreed that climate change, emerging technologies and the health of indigenous
populations presented distinct sets of ethical challenges. However, they recognized that the topics
were inter-related and that strengthening the capacities of NECs through improved
policy development, continued revision and review of guidelines, frameworks and standard operating
procedures (SOPs), strengthening accountability over Institutional Review Boards (IRBs) and other
research oversight bodies, and strengthening national and regional networking for ethics/bioethics,
were important to reducing health inequities through solutions-orientated bioethics.
Member States were encouraged to strengthen NECs through improved policy, administrative
support, financing and prioritizing challenges and opportunities in significant areas, including climate
change, emerging technologies and the health of indigenous populations. They suggested the
development of ethics preparedness, the reviewing and revising protocols for research conducted in
post-emergency settings to support evidence-based responses to climate change; the development of
climate-change leadership; strengthening knowledge of emerging technologies for NEC members; the
development of ethical frameworks for data- and benefit-sharing that minimize harm and misuse; the
use of culturally competent ethical guidance and training for researchers and health professionals,
including the use of alternative ethical principles, such as Te Ara Tika, which reflect local values; the
development of wholistic guidelines on community engagement; and addressing unethical behaviours
in research, e.g. ethics dumping. NECs should seek to engage more proactively with the public,
including through civil society. Recognizing that health equity impacts and is impacted by many
sectors beyond health, NECs should increase national collaboration with government agencies in
addition to ministries of health. Moreover, NECs should evaluate the way that they are working and
promoting health ethics when presented with challenges where the current paradigm of solutions, such
as the development of guidelines and/or reports, may be inadequate or ill-suited.
WHO was requested to provide support to provide assistance to Member States in advancing actions
for health ethics, such as through supporting the establishment of NECs, support for specialist training
on technical areas and ethics processes, e.g. writing guidelines; the facilitation of country-to-country
learning; and the development of international guidelines and standards on specialist topics, e.g. use
of artificial intelligence in health and climate change–related ethical guidance. Member States
expressed interest participating in future health ethics meetings, including in the 13th Global Summit
of National Ethics/Bioethics Committees in 2020 and the next Asia-Pacific Regional Meeting for
National Ethics/Bioethics Committees, possibly in 2021.
5
1. INTRODUCTION
Bioethics promotes the consideration of values in the prioritization and justification of actions by
health professionals, researchers, and policymakers that may impact the health and well-being of
patients, families, and communities. Bioethics is an interdisciplinary field encompassing a broad
range of domains and issues.
A bioethics framework provides for a systematic analysis and resolution of conflicts through an
evidence-based application of general ethical principles, such as respect for personal autonomy,
beneficence, justice, utility, and solidarity. Bioethics provides a framework of values and principles,
through which the ethical significance of key health issues can be understood, analysed and
appropriate solutions can be developed.
Equity is an ethical principle that aligns with and is closely related to human rights principles, and
particularly the right to health, that is the enjoyment of the highest attainable standard of physical and
mental health. Equity in health is the absence of avoidable or remediable differences among groups of
people, whether those groups are defined socially, economically, demographically or geographically.
These differences often determine the health status of individuals, either by directly influencing their
health, or indirectly by influencing their ability to access health care. Global change underpins issues
of health inequity, among these are the issues of climate change, emerging technologies and the health
and well-being of indigenous populations.
Bioethics has a role to play in in addressing health inequity at both nationally and internationally.
Solutions-orientated bioethics draws on the practical aspects of bioethics, where real world situations
are analysed using a bioethics framework. Bioethical analysis is an important tool in addressing and
resolving health inequities.
To ensure that the practice of solutions-orientated bioethics is integrated into how health inequity is
addressed, there is a need to work with and strengthen the roles of national ethics/bioethics
committees across the areas of public health, clinical care and health research. As such, reducing
health inequities is reinforced by robust systems that develop health ethics, both in principle and in
practice.
1.1 Meeting organization
The Second Asia-Pacific Regional Meeting for National Ethics/Bioethics Committees (AP-NEC2)
was convened in Wellington, New Zealand, from 22 to 23 October 2019. AP-NEC2 was chaired by
Kāhui Matatika o te Motu - the National Ethics Advisory Committee of New Zealand (NEAC), with
support from the World Health Organization (WHO) in collaboration with the United Nations
Educational, Scientific and Cultural Organization (UNESCO). AP-NEC2 was attended by 34
delegates from 22 countries, including 18 from the Western Pacific Region (Brunei Darussalam,
Cambodia, China, Cook Islands, Fiji, Japan, Malaysia, Mongolia, New Zealand, Palau, Philippines,
Papua New Guinea, Republic of Korea, Samoa, Singapore, Solomon Islands and Viet Nam) and five
from the South-East Asia Region (Bangladesh, Bhutan, Indonesia, Nepal, Thailand). Delegations
comprised the chairs of national ethics/bioethics committees (NECs) or equivalent advisory groups
that guide the government on health ethics issues and senior officers in the Ministry of Health (MoH)
or other government agencies responsible for the development, implementation and/or evaluation of
health ethics policies, guidelines and programmes.
1.2 Meeting objectives
The objectives of the meeting were:
(1) To highlight the role of health ethics in reducing inequities, in the context of priority global,
regional and national issues;
(2) To develop solutions, including to identify opportunities for multisectoral engagement and
international cooperation towards advancing action on priority issues; and
6
(3) To strengthen national capacities for bioethics, including through national ethics/bioethics
committees.
2. PROCEEDINGS
2.1 Opening session
The meeting was opened by a formal Mihi (greeting) and karakia. A welcome address was delivered
by the Honourable Jenny Salesa, the Associate Minister of Health, New Zealand. She focused on the
timely nature of the theme of the meeting and the need to focus on solutions to bring about
meaningful health. She noted that the theme of the meeting was ambitious in scope highlighting that
in the face of climate change, emerging technologies and the needs of indigenous populations, which
held particular importance to New Zealand, that significant changes needed to be made in the
allocation of resources to health and the design and delivery of health services to ensure a more
sustainable and fairer health system. Following the Minister’s remarks was a Waiata (song) from the
Ministry of Health New Zealand and NEAC members and formal welcome remarks from Dr Neil
Pickering, Chairperson of NEAC, Mr Irakli Khodeli from UNESCO and Dr Tasnim Azim from
World Health Organization Regional Office for South East Asia Region (SEARO).
Mr Darryl Barrett for WHO Regional Office for the Western Pacific (WPRO) delivered an
introductory presentation setting out the objectives of the meeting for participants. Building on the
First Asia-Pacific Regional Meeting for National Ethics/Bioethics Committees held in Seoul,
Republic of Korea, from 24 to 25 October 2017, the presentation highlighted the three main streams
of health ethics: public health, clinical care ethics and health-related research ethics and introduced
the three topic areas for AP-NEC2: climate change, emerging technologies and indigenous
populations and health, and underscored the relationship each topic has with health equity. Whereas
NECs have a role in ensuring that health policies and procedures and protocols in clinical care and
research centred health equity, AP-NEC2 aimed at strengthening the role that NECs can play in their
countries’ paths to sustainable development.
2.2 Technical Sessions
2.2.1 Session 1: Climate Change, Ethics, Equity and Health
2.2.1.1 Technical presentation: Climate Change and Health Ethics
Dr Rhys Jones, Senior Lecturer
Faculty of Medical and Health Sciences, University of Auckland
The technical presentation discussed the need to respond to the serious ethical questions raised by
climate change within public health, health research and clinical care. The unequal health impact from
climate change exists between nations and within nations. The health care sector has a role in
contributing to climate change and has responsibility in mitigating and adapting to climate change.
There is an opportunity to improve health and address the underlying inequity that contributes to ill-
health through climate change adaptation e.g. through investment in active transport and sustainable
homes and buildings. Equity behoves nations to not simply continue on a path that is the same but a
little greener, but instead to move forward in a spirit of environmental and health justice. An honest
consideration of the context of colonialism, racism, disenfranchisement and oppression is part of
considering justice, in developing bodies of knowledge that are inclusive and can serve marginalized
populations. Participants were urged to consider their roles and embrace their potential in dismantling
inequities to improve health whilst addressing climate change.
2.2.1.2 Report: Results of the Country Survey on Climate Change and Health Ethics
in the Asia-Pacific Region
Ms. Dena Kirpalani, Consultant, Health Law & Ethics Unit
Division of Health Systems, WHO Regional Office for the Western Pacific
7
An overview of the key conclusions from the country survey that was circulated to participants prior to
the meeting was presented. The survey asked participants to identify who held responsibility for ethics-
based decision making on a topic, what steps countries had made to use ethics or ethics institutions to
tackle the subject and identify what they perceived to be key ethical challenges within the topic and
specifically as those challenges relate to equity to orientate the participants to the theme of solutions
orientated bioethics.
Many countries in the region had specialist bodies, plans and strategies in place to address and
coordinate climate change responses. The impact of climate change on marginalized populations, the
impact of pre-existing health inequity and living status disparities were cited as key ethical concerns.
2.2.1.3. Country Panel
Country participants were invited to provide reflections and updates on health ethics,
inequity and climate change from their country perspectives:
2.2.1.3.1. Bangladesh: Research ethics and climate change: knowledge of
research ethics among doctors
Research was undertaken in Bangladesh to assess medical knowledge of
ethics amongst doctors. There was a gap between an awareness and
understanding of ethics, its application within clinical care, research and in
public health issues e.g. climate change. It recommended integration of ethics
into the curriculum for health professionals.
2.2.1.3.2. Nepal: Role of national organization in climate change adaptation
and mitigation
Climate change will have an impact on health in Nepal e.g. diminished food
security. Coordination was required between stakeholders, policies and
guidelines needs to be resourced and implemented.
2.2.1.3.3. Republic of Korea: Climate change-related strategic plan in the
Republic of Korea – inequities and privacy issues
The Korean Centre for Disease Control (KCDC) has established a division of
Future Disease Preparedness to support responses to climate change. The
Framework Act on Low Carbon, Green Growth, Climate Change Adaptation
Plan and Framework Act on Health and Medical Services all support climate
change responses.
2.2.1.3.4. Fiji
Small island states (SIS) face enhanced challenges from climate change.
There is a need for emergency preparedness and an analysis of ethics in post-
disaster situations as the frequency of natural disasters increases due to climate
change.
2.2.1.4. Group Work 1: Climate Change, Ethics, Equity and Health
Participants were organized into three self-selected groups based on each stream of health
ethics: public health ethics, research ethics and clinical ethics. They were each asked to identify
challenges and actions to reduce inequities in health status that related to or impacted by
climate change. Outcomes from the group work are summarised in the table at Annex 3.
2.2.2. Session 2: Emerging Technologies, Ethics, Equity and Health
2.2.2.1. Technical presentation: People centric approaches to ensure equity in the
development of ethical guidelines for biomedical and health research in
emerging technologies
Dr Roli Mathur, Scientist F & Head of ICMR Bioethics Unit
National Centre for Disease Informatics and Research
Innovative technologies hold the possibility of improving health, shifting our understanding of systems
and information. However, technological progress does not guarantee equitable health outcomes. Equity
needs to be integrated into the way that research is conducted. This is especially urgent as new
technologies challenged established frames of privacy and confidentiality, bodily autonomy and
8
equitable benefit sharing. Research, and guidelines and processes for research need to people centric
that is research needs to be for the people, by the people and with the people. Greater knowledge of new
technologies is needed to monitor and assess the impact of new technologies. Policy pathways should
ensure justice.
2.2.2.2. Report: Results of the Country Survey on Emerging Technologies and Health
Ethics in the Asia-Pacific Region
Ms. Dena Kirpalani, Consultant, Health Law & Ethics Unit
Division of Health Systems, WHO Regional Office for the Western Pacific
There was an interest in a range of emerging technologies and their impact. New legislation, regulation,
protocols and guidelines had been developed to address concerns arising from emerging technologies.
Potential inappropriate use, exploitation of marginalized populations, privacy, confidentiality and data
security and appropriate and adequate delivery of new technologies needed to be addressed in the work
of NECs and MoH.
2.2.2.3. Country Panel
Country participants were invited to provide reflections and updates on health ethics, inequity and
emerging technologies from their country perspectives:
2.2.2.3.1. China: Establishing National Ethics Committee on Science &
Technology – Update from China
The National Ethics Committee on Science and Technology is responsible for
coordinating ethics and harmonizing responses between research institutions. It
supports capacity-building and ethics education for research institutions. It monitors
the development of new technologies and develops regulations for the implementation
of new technologies.
2.2.2.3.2. Japan: Second report on the revision of the “Basic Principles on
Handling of Human Embryos” (2019)
The Cabinet Office tackles high-level policy questions on both basic and health
research. It has developed a framework on the handling of human embryos in research.
2.2.2.3.3. Mongolia: Health equity in Mongolia
MoH is working on the reduction of financial barriers to health services to improve
equitable access to health technologies e.g. haemodialysis. Guidelines on that support
health equity and governance are also being supported.
2.2.2.3.4. Singapore: Translation of emerging technology into clinical practice:
a case study on PGS in Singapore
The transition of emerging technologies from research to clinical application quires
guidance. Singapore has a licensing and regulatory framework for health professionals
and institutions carrying out pre-implantation genetic screening (PGS). The framework
was developed through an assessment of the risks and potential benefits, supported by
a pilot program and an effort to create an inclusive criteria for pilot participants.
2.2.2.3.5. Indonesia: Ethics of Emerging Technologies
Four areas within emerging technologies were highlighted: the disruptive power of new
technologies and how to understand these, the on-going challenge of equitable
distribution of benefits and burdens, how to govern technological innovation when it
happens outside the purview of governments, and how to keep pace with innovation.
2.2.2.3.6. Vietnam: Review process of Investigational New Drug (IND) studies
in Vietnam
9
Vietnam has a legal and regulatory system in place for processing ethical approvals for
drug and vaccine trails on human subjects. Vietnam has relied on WHO Guidelines to
develop this system that has approval levels at the institutional, provincial and central
levels.
2.2.2.3.7. Philippines: Stem cell facility regulation in the Philippines
The Bioethics Advisory Board Committee developed a regulatory framework for stem
cell facilities. They considered contentious ethical, scientific, legal issues in stem cell
and cellular-based research and therapeutics. The regime provides facility based
regulatory oversight and distinguishes between facilities involved in research versus
clinical application. It has developed a bench-marking system for assessing facilities.
2.2.2.3.8. Thailand: Ethics of Science and Technology for Sustainable
Development
Thailand is discussing a draft law on climate change to reduce greenhouse gas
emissions and to provide financing for climate change solutions. An understanding of
climate change and human rights is a means of supporting scientific integrity to achieve
the Sustainable Development Goals (SDGs).
2.2.2.3.9. Fiji
Fiji engaged in a review of their ethics policies and SOPs. It is working to develop an
accreditation system for IRBs. Stronger IRBs provide oversight for projects (domestic
and international) and to address concerns around the use of new technologies and to
reduce the risk of unethical practices e.g. ethics dumping. Regional support can help
address in-country capacity limitations and reduce forum shopping by researchers
looking for the least restrictive jurisdiction.
2.2.2.4. Group Work 2: Emerging Technologies, Ethics, Equity and Health
Participants were organized into three self-selected groups based on each stream of health
ethics: public health ethics, research ethics and clinical ethics. They were each asked to identify
challenges and actions to reduce inequities in health status that related to or impacted by
emerging technologies. Outcomes from the group work are summarised in the table at Annex
3.
2.2.3 Session 3: Indigenous Populations, Ethics, Equity and Health
2.2.3.1. Technical presentation: Supporting equity in Health Ethics with Indigenous
Populations: The Aotearoa New Zealand Experience
Mr. Maui Hudson, Associate Professor
Faculty of Māori and Indigenous Studies, University of Waikato
The topic of indigenous populations is linked to both climate change and emerging technologies. The
New Zealand experience has integrated indigenous viewpoints within an understanding of health
equity. This has a relevance to other country experiences in both understanding the position of ethics
and cultural minorities and other marginalized populations, and in confronting and deconstructing
histories of colonialization and their impacts on public health and health systems. The Te Ara Tika
Guidelines for Māori Research Ethics and the National Standards for Health and Disability Ethics
(the Guidelines) is an example of how indigenous values or alternative ethical principles are
increasingly relevant in bioethical analyses and integrated into health-related ethical guidance. The
Guidelines developed a cultural principles framework which integrated key Māori ethical concepts
and were developed with structured Māori participation. This was also reflected in He Tangata Kei
Tua: Guidelines for Biobanking with Māori and Te Mata Ira: Guidelines for Genomic Research with
Māori. Four points at the intersection between indigenous populations and health and health equity
were highlighted: (1) incorporating indigenous values (2) supporting indigenous participation (3)
addressing equity and indigenous outcomes and (4) enhancing indigenous control of indigenous data.
2.2.3.2. Report: Results of the Country Survey on Indigenous Populations and Health
Ethics in the Asia-Pacific Region
10
Ms. Dena Kirpalani, Consultant, Health Law & Ethics Unit
Division of Health Systems, WHO Regional Office for the Western Pacific
There was an interest in understanding the topic by participants. There were recent developments in
legislation and regulation and the development of protocols and guidelines across the region that
focused on equitable engagement with indigenous populations within health-related research. The
inequitable health outcomes for indigenous populations in some jurisdictions was also a concern.
2.2.3.3. Country Panel
Country participants were invited to provide reflections on updates on health ethics, inequity and
indigenous populations from their country perspectives:
2.2.3.3.1. Palau: Promoting ethics and reducing inequities in small island states
Palau’s National Institutional Research Board (NIRB) was established in 2018 and has
a role in safeguarding the rights and interests of the people of Palau. It has a role in
protecting the people of Palau from exploitative research and to ensure that benefits
from research are shared. There is an integration of traditional forms of consent and
knowledge into the NIRB’s processes.
2.2.3.3.2. Philippines: Mainstreaming health research involving indigenous
peoples
Indigenous populations in the Philippines have inequitable health outcomes. Research
with and within indigenous communities requires authentic representation from
indigenous peoples. Reforms were being undertaken in the Philippines to empower
indigenous peoples to participate meaningfully in research, improve the awareness of
researchers and the public and require that research studies integrate indigenous
considerations to acquire clearance for research.
2.2.3.3.3. Cook Islands: Injuries – research ethics
The Pacific Health Ministers Meeting 2019 emphasised the impact of climate change
on the Pacific, the need to indigenize research and ensure that climate change research
benefited SISs. Cook Islands is exploring the creation of a national interdisciplinary
committee to develop research guidelines that protect Cook Islanders and create access
to the benefits of the research, such as the ability to use research in policy development
and decision-making.
2.2.3.3.4. Cambodia: How to address effectively the ethical issues in Cambodia?
Cambodia’s National Ethics Committee for Health Research (involving human
subjects) was established in 2002. Its most important documents are its National Ethical
Guidelines and SOPs that were developed in 2008. The Committee is currently
updating its SOPs. Health professional councils have some oversight over clinical care
ethics. There is no body committed to consideration of public health ethics.
2.2.3.3.5. Bhutan: Research ethics
Bhutan’s framework for regulating traditional medicine and research in traditional
medicine incorporates indigenous values. The integration of religious and
philosophical aspects of traditional medicine is important for the application of
traditional medicine in Bhutan. There is a need to develop global ethical standards
within traditional medicine research that ensures the incorporation of indigenous value
systems, including protection of benefit sharing and accessibility of results.
2.2.3.4. Group Work 3: Indigenous populations, Ethics, Equity and Health
Participants were organized into three self-selected groups based on each stream of health
ethics: public health ethics, research ethics and clinical ethics. They were each asked to identify
challenges and actions to reduce inequities in health status that related to or impacted by
11
indigenous populations and indigenous values. Outcomes from the group work is summarised
in the table at Annex 3.
2.2.4. Session 4: Challenges and opportunities in strengthening national capacities for
health ethics
Both WHO and UNESCO support countries in strengthening capacities for NECs
2.2.4.1. Technical presentation: UNESCO and Global Bioethics: from International
Standard-Setting to National Capacity-building
Mr. Irakli Khodeli, Social and Human Sciences Sector
UNESCO Science Bureau for Asia and the Pacific
UNESCO is involved in: (1) global standard setting and instruments e.g. Universal Declaration on
Bioethics and Human Rights (2) global reflection e.g. UN Inter-Agency Committee on Bioethics and
(3) capacity-building action at the national level e.g. UNESCO’s Ethics Education Program.
2.2.4.2. Technical presentation: Supporting Member States in Strengthening
National Capacities for Health Ethics
Dr Ki-hyun Hahm, Technical Officer, Health Law and Ethics Unit, Division of
Health Systems, WHO Regional Office for the Western Pacific
Dr. Changgyo Yoon, Technical Officer, WHO Representative Office for the South
Pacific
Dr. Tasnim Azim, Regional Adviser, Department of Communicable
Diseases, WHO Regional Office for South-East Asia
WHO’s objectives include articulating ethical and evidence-based policy options. Strengthening
capacities for research ethics directly in countries and through regional programs remains a key part of
delivering this objective. WHO ethics related initiatives and resources at the global level include: WHO
Ethics Review Committee, Public Health Ethics Consultative Service, WHO Collaborating Centres for
Bioethics Network and Global Summits.
2.2.4.3. Country Panel
Country participants were invited to provide reflections on updates on changes and opportunities to
strengthen national capacities for health ethics from their country perspectives:
2.2.4.3.1. Nepal: National Ethical Guideline, SOP & Operation Modality
The Nepal National Ethics Committee (NNEC) was established under the Nepal Health
Research Council Act 1991. The volume and scope of research undertaken in Nepal
has grown. The NNEC recently revised national ethical guidelines for health research
with support from WHO and ICMR. The NNEC has also developed a web-portal
system for submissions of research proposals. It has a monitoring and evaluation
framework in place to assess research proposals which include an obligation to protect
marginalized people from harm under the research process. Nepal is applying for
FERCAP-SIDCER accreditation.
2.2.4.3.2. Solomon Islands: Strengthening Provincial Health Research System:
Utilizing the Research Capacity Building Initiative
A research capacity survey was conducted in the Solomon Islands in 2009. It found
that research was almost exclusively led by external researchers, so the wealth of data
collected was not being used to the benefit of local populations. Solomon Islands
established a health research and ethics review board to review applications for
research within the Solomon Islands in 2012. The board however has limited capacity
to coordinate between the capital and the provinces. There has been an investment in
research training capacity building to improve provincial skills and coordination.
2.2.4.3.3. India: Central Ethics Committee on Human Research – National
Ethics Committee
12
The Indian Council of Medical Research (ICMR) promotes and formulates biomedical
and health research and is situated within the Ministry of Health. The Central Ethics
Committee on Human Research (CECHR) is appointed by the Director General of
ICMR to develop guidance for biomedical and health research. CECHR produces
guidance, policy and regulations, works on capacity building for researchers, students,
research institutes etc. and supports health and science collaboration and
communication. The CECHR’s upcoming activities include focus on the use of
advanced directives, do not attempt resuscitation (DNAR) requests, withdrawal or
withholding of treatment and end of life care, a review of the guidelines for multicentre
research, developing a national conflict of interest policy and national guidelines for
research on tribal populations.
2.2.4.3.4. New Zealand: Developing National Standards for Health and
Disability Research and Quality Improvement
The development of the national Standards for Health and Disability Research and
Quality Improvement included a few public consultations that incorporated four major
themes: inclusion, representation and fairness, appropriate safeguards, and accessibility
and commitment to advancing knowledge. The result of the consultations was an
identification of shortcomings in the data on Māori populations and the need for
dynamic standards to respond to technological development. Part of the solution was
to make the Standards a living document, that is it would not be printed and would be
updated periodically to keep pace with changes in design and technology.
2.2.4.3.5. Singapore: Incorporating the Bioethics Advisory Committee’s
guidelines into Singapore’s Human Biomedical Research Act (2015)
The Bioethics Advisory Committee (BAC) is an independent advisory committee that
was established in 2000 as Singapore’s national advisory body with a mandate to
address the ethical, legal and social issues arising from biomedical research and
develop and recommend policies to the Singaporean government. The BAC has three
work streams: advisory, international engagement and education over a range of
biomedical topics from gene-editing and data privacy before formulating its guidelines
on biomedical research. Its recommendations led to the development of the Human
Biomedical Research Act 2015.
2.2.4.3.6. Papua New Guinea: PNG National Health Plan 2011 – 2020
The PNG National Health Plan 2011 – 2020 hopes to tackle eight (8) key areas and
requires research strengthening to support these and their associated outcomes. It is
part of current reforms to introduce a role delineation model of service delivery.
2.2.4.3.7. Indonesia: Legitimate Health Research by International Ethical
Standard
Indonesia has developed a consolidated website for all its IRBs. It is also training IRBs
and their members. The Indonesian National Ethics Committee (INEC) provides a
three-day basic training course and all IRB members must be certified by the INEC.
The INEC also has facility for IRBs to submit their protocols electronically for approval.
Indonesia will roll out a program for accrediting IRBs from 2020.
2.2.4.3.8. Samoa
Samoa has two bodies overseeing health research ethics: the National Health Research
Committee (NHRC) that reviews and approves research studies, and the National
University of Samoa Ethics Committee that reviews and approves university research
projects. Professional ethics are overseen by the Public Service Commission (labour).
Medical ethics are addressed by the Samoa Medical Association (medical ethics).
There is a recognition that the NHRC’s work requires greater visibility and
transparency, and there is a need to ensure indigenous populations are protected during
13
research. Samoa’s system is rudimentary and there is a need to train local researchers,
educate populations and strengthen policies and regulation for health-related research.
2.2.5. Session 5: Ways Forward
Participants engaged in a country planning exercise. They planned out their immediate, short and long-
term objectives, how they intended to achieve them and what support from WHO or UNESCO could
support them utilizing the conclusions from the group work exercises over the course of the meeting
(See Annex 4). The goal was to take the learnings from the meeting and translate this to concrete actions.
The results were sent to the WHO for collation. The priorities identified are summarised in the
conclusion.
2.2.6. Closing Ceremony
Mr Barrett, Dr Azim, Mr Khodeli and Dr Pickering provided closing remarks to the room. They thanked
the participants for their engagement, their dedication to realizing health equity within their roles and
the practical suggestions that would be taken forward from the meeting. A formal closing was given by
Maui Hudson.
14
3. CONCLUSIONS AND RECOMMENDATIONS
3.1 Conclusions
Participants agreed on the following:
(1) Considerable variation continues to exist among countries in their institutional arrangements
and capacities for health ethics, but there are opportunities for collaboration among countries
to establish and strengthen national capacities/
(2) Countries with more advanced systems for health ethics expressed a wish to continue to provide
support for countries that are developing their national health ethics frameworks.
(3) Countries and national ethics/bioethics committees should continue to develop, review and
revise their guidelines, frameworks and SOPs, and strengthen their expertise and networks so
they are responsive to the new challenges presented by climate change and emerging
technologies, develop processes that incorporate consultation with local populations, address
industry influence and conflicts of influence, and develop culturally competent ethics training
and education.
(4) Countries should improve coordination between ministries, NECs and other research oversight
bodies and their engagement with other stakeholders on matters of health, inequities and
specific areas such as climate change, emerging technologies and indigenous populations.
(5) Countries and national ethics/bioethics committees should support transparency and
accountability mechanisms over institutional review boards (IRBs) and/or other research
oversight bodies to ensure standards and guidelines align with international standards and
guidelines.
3.2 Recommendations
3.2.1 Recommendations for Member States
Member States are encouraged to do the following:
(1) to continue to work towards the establishment of national ethics/bioethics committees or other
oversight bodies, as appropriate, where these do not exist;
(2) to continue to revise/update guidelines and frameworks and create SOPs, as appropriate;
(3) to strengthen national ethics/bioethics committees through improved policy, administrative
support, financing and better integration with challenges and opportunities in priority areas,
including climate change, emerging technologies and the health of indigenous populations, such
as through:
3.1. the development of ethics preparedness, the reviewing and revising protocols for research
(including multi-country research) conducted in post-disaster and post-emergency settings to
allow for rapid approval of research needed to gather data and respond to climate change;
3.2. the development of climate-change leadership in health care and health research;
3.3. the strengthening of knowledge of emerging technologies for members of national ethics
committees;
3.4. the development of ethical frameworks for data- and benefit-sharing that minimize harm and
misuse, and facilitate equitable health outcomes;
3.5. the development and integration of culturally competent ethical guidance and training for
researchers and health professionals;
3.6. the development of wholistic guidelines on community engagement for researchers,
including on matters of informed consent, and appropriate support for communities
engaging in research; and
3.7. the development of processes to address unethical processes in research, e.g. ethics dumping
and exploitation of indigenous populations in research, and the safeguarding of local
15
populations;
(4) to strengthen accountability over IRBs and other research oversight bodies;
(5) to develop ethics training and, if not already in place, introduce ethics into the curricula for
health professionals and researchers, linking such training and guidance with WHO and
UNESCO frameworks, and integrating cultural competencies into such training and guidance, as
appropriate; and
(6) to strengthen national and regional networking and sharing for ethics/bioethics.
During the Session 5, participants identified country-specific actions they considered undertaking at
the conclusion of the meeting. These are contained in the documents included at Annex 4.
3.2.2 Recommendations for WHO
WHO is requested to do the following:
(1) to provide assistance to Member States in advancing actions for health ethics,
such as through:
1.1. the establishment of national ethics/bioethics committees;
1.2. support for specialist training on technical areas and ethics processes, e.g.
writing guidelines or reviewing existing guidance and policies;
1.3. the facilitation of country-to-country learning; and
1.4. the development of international guidelines and standards on specialist topics,
e.g. use of artificial intelligence in health, treatment of human biological data,
data- and benefit-sharing, and climate change–related ethical guidance;
(2) to support the organization of the Third Asia-Pacific Regional Meeting for National
Ethics/Bioethics Committees in 2021.
16
ANNEXES
Annex 1. List of participants, temporary adviser, observers/representatives and Secretariat
1. PARTICIPANTS
Mahmood Uz Jahan, Director, Bangladesh Medical Research Council, Dhaka, Bangladesh.
E-mail: [email protected]
Kinley Dorjee, Assistant Research Officer, Health Management and Information Unit, Ministry of
Health, Thimpu, Bhutan. E-mail: [email protected]
Suzylawati PG Ismail, Deputy Senior Legal Counsel, Ministry of Health,
Bandar Seri Begawan, Brunei Darussalam. E-mail: [email protected]
Alice Moi Ling Yong, Endocrinologist Consultant, Ministry of Health, Bandar Seri Begawan,
Brunei Darussalam. E-mail: [email protected]
Chap Seak Chhay, Deputy Director General, Administration and Finance, Member, Secretariat of the
National Ethics Committee for Health Research Involving Human Subjects in Cambodia
Ministry of Health, Phnom Penh, Cambodia. E-mail: [email protected]
Liu Guisheng, Division Chief, Planning and Evaluation, Division of Asian, American and Multilateral
Affairs, Department of Science, Technology and Education, National Health Commission
Beijing, People’s Republic of China. E-mail: [email protected]
Zhai Xiaomei, Executive Director, Center for Bioethics, Peking Union Medical College
Beijing, People’s Republic of China E-mail: [email protected]
Nuhisifa Seve-Williams, Research Manager, Ministry of Health, Rarotonga, Cook Islands.
E-mail: [email protected]
Eric Rafai, Head, Research & Innovation, Data Analysis and Management, Ministry of Health &
Medical Services, Suva, Fiji. E-mail: [email protected]
Triono Soendoro, Head, National Health Ethics and Development, Ministry of Health
Jakarta, Indonesia. E-mail: [email protected]
Mika Shigematsu, Deputy Director, Science and Technology Policy, Bureau of Science, Technology
and Innovation, Tokyo, Japan. E-mail: [email protected]
Bang-ook Jun, Department of Biology, Gangneung-Wonju National University
Wonju, Republic of Korea. E-mail: [email protected]
Eun Kyoung Choi, Human Material Policy Research, Korea National Institute for Bioethics Policy
Seoul, Republic of Korea. E-mail: [email protected]
Hannah Moon, Human Material Policy Research, Korea National Institute for Bioethics Policy
Seoul, Republic of Korea. E-mail: [email protected]
17
Douangdao Soukaloun, President, National Ethics Committee for Health Research of Lao PDR,
Vientiane, Lao People’s Democratic Republic. E-mail: [email protected]
Salina Binti Abdul Aziz, Chairperson, Medical, Research, Ethics Committee, Ministry of Health
Kuala Lumpur, Malaysia. E-mail: [email protected]
Mohd Noor Musa, Special Officer, Institute of Islamic Understanding Malaysia, Kuala Lumpur,
Malaysia. E-mail: [email protected]
Enebish Oyunsuren, Officer, Research and Innovation and Technology, Ministry of Health,
Ulaanbaatar, Mongolia. E-mail: [email protected]
Prakash Ghimire, Chair, Ethical Review Board, Nepal Health Research Council, Kathmandu, Nepal.
E-mail: [email protected]
Aarati Shah, Chair, Ethics Committee, National Academy of Medical Sciences, Bir Hospital,
Kathmandu, Nepal. E-mail: [email protected]
Neil Pickering (Chair of AP-NEC2), Chair, National Ethics Advisory Committee, Otago,
New Zealand. E-mail: [email protected]
Nic Aagaard, Principal Advisor, Ethics, Quality Assurance and Safety, Health System Improvement
and Innovation, Ministry of Health, Wellington, New Zealand. E-mail: [email protected]
Gaafar Sers Jose Uherbalau, Administrator, Health Policy, Research and Development Office
Ministry of Health, Koror, Palau. E-mail: [email protected]
Maluo Magaru, Technical Adviser, Hospital Operations, National Department of Health,
Port Moresby, Papua New Guinea. E-mail: [email protected]
Leonardo de Castro, Chair, Philippine Health Research Ethics Board, Department of Philosophy
University of the Philippines, Quezon City, Philippines. E-mail: [email protected]
Kathleen Grace Lentija, Secretariat, Bioethics Advisory Board Committee for the Regulation of
Health Facilities Engaging in Human Stem-cell, Cell-based or Cellular Therapies in the Philippines
Licensing Officer III, Department of Health, Manila, Philippines. E-mail: [email protected]
Filipina Amosa-Lei Sam, Pathologist, Meaole Hospital, Ministry of Health, Apia, Samoa.
E-mail: [email protected]
Richard Magnus, Chair, Bioethics Advisory Committee, Ministry of Health, Singapore.
E-mail: [email protected]
Sharon Bala Krishnan-Thomas, Deputy Director, Precision Medicine and Research Branch,
Regulatory Policy and Legislation Division, Ministry of Health, Singapore.
E-mail: [email protected]
18
Devanand Anantham, Deputy Chair, National Medical Ethics Committee, Singapore.
E-mail: [email protected]
Hsi-Yen Loke, Medical Officer, Bioethics Advisory Committee Secretariat, Ministry of Health
Singapore. E-mail: [email protected]
Raymond Chua, Group Director, Health Regulation Group, Ministry of Health, Singapore.
E-mail: [email protected]
Freda Pitakaka, Chief Research Officer, Solomon Islands Health Research and Ethics Review Board
Secretariat (SIHRERB), Ministry of Health Medical Services, Honiara, Solomon Islands.
Email: [email protected]
Yuthavong Yongyuth, Advisor, National Committee on Ethics of Science and Technology
Bangkok, Thailand. E-mail: [email protected]; [email protected]
Nguyen Ngo Quang, Acting Director, Administration of Science, Technology and Training
Ministry of Health, Hanoi, Viet Nam. E-mail: [email protected]
2. TEMPORARY ADVISERS
Maui Luke Hudson, Associate Professor, Faculty of Maori and Indigenous Studies, University of
Waikato, Hamilton, New Zealand. E-mail: [email protected]
Rhys Jones, Senior Lecturer – Medical, Faculty of Medical and Health Sciences, University of
Auckland, Auckland, New Zealand. E-mail: [email protected]
Roli Mathur, Scientist F and Head, ICMR Bioethics Unit, National Centre for Disease Informatics and
Research, Bengaluru, India. E-mail: [email protected]
3. OBSERVERS/REPRESENTATIVES
Colin Gavaghan, Advisory Committee for Assisted Reproductive Technologies, New Zealand
Helen Walker, Central Health and Disability Ethics Committee, New Zealand
Rochelle Style, Health and Disability Ethics Committee, New Zealand
Huia Tomlins-Jahnke, Health Research Council Ethics Committee, New Zealand
Maureen Holdaway, National Ethics Advisory Committee, New Zealand
Wayne Miles, National Ethics Advisory Committee, New Zealand
Liz Richards, National Ethics Advisory Committee, New Zealand
Hope Tupara, National Ethics Advisory Committee, New Zealand
19
Dana Wensley, National Ethics Advisory Committee, New Zealand
Mary-Anne Woodnorth, National Ethics Advisory Committee, New Zealand
Gordon Jackman, National Ethics Advisory Committee, New Zealand
Manuka Henare, Northern A Health and Disability Ethics Committee, New Zealand
Kate O’Connor, Northern B Health and Disability Ethics Committee, New Zealand
Lynley Anderson, eOtago University Bioethics Centre, New Zealand
Sarah Gunningham, Southern Health and Disability Ethics Committee, New Zealand
Angela Ballantyne, University of Otago, New Zealand
4. SECRETARIAT
World Health Organization
Darryl Barrett, Coordinator, Health Law and Ethics, Division of Health Systems and Services, WHO
Regional Office for the Western Pacific, Manila, Philippines. E-mail: [email protected]
Ki-Hyun Hahm (WHO Responsible Officer for AP-NEC2), Technical Officer, Health Law and
Ethics, Division of Health Systems and Services, WHO Regional Office for the Western Pacific,
Manila, Philippines. E-mail: [email protected]
Dena Kirpalani, Consultant, Health Law and Ethics, Division of Health Systems and Services, WHO
Regional Office for the Western Pacific, Manila, Philippines. E-mail: [email protected]
Changgyo Yoon, Technical Officer, WHO Representative Office for the South Pacific, Suva, Fiji.
E-mail: [email protected]
Tasnim Azim, Regional Adviser, Department of Communicable Diseases, WHO Regional Office for
South-East Asia, New Delhi, India. E-mail: [email protected]
New Zealand Ministry of Health
Margaret Earle, Principal Advisor, Office of the DDG Population Health and Prevention, Ministry of
Health, Wellington, New Zealand
Kirsten Forrest, Senior Advisor, Ethics, Quality Assurance and Safety, Health System Improvement
and Innovation, Ministry of Health, Wellington, New Zealand
Mark Joyce, Advisor, Ethics, Quality Assurance and Safety, Health System Improvement and
Innovation, Ministry of Health, Wellington, New Zealand
20
Tristan Katz, Advisor, Ethics, Quality Assurance and Safety, Health System Improvement and
Innovation, Ministry of Health, Wellington, New Zealand
Martin Kennedy, Senior Policy Analyst, Ethics, Quality Assurance and Safety, Health System
Improvement and Innovation, Ministry of Health, Wellington, New Zealand
Rob McHawk, Manager, Ethics, Quality Assurance and Safety, Health System Improvement and
Innovation, Ministry of Health, Wellington, New Zealand
Courtney Parnell, Administrator, Ethics, Quality Assurance and Safety, Health System Improvement
and Innovation, Ministry of Health, Wellington, New Zealand
Hayley Robertson, Senior Advisor, Ethics, Quality Assurance and Safety, Health System
Improvement and Innovation, Ministry of Health, Wellington, New Zealand
Clyde Smith, Policy Analyst, Maori Health, Strategy and Policy, Ministry of Health, Wellington, New
Zealand
Joel Tyrie, Advisor, Ethics, Quality Assurance and Safety, Health System Improvement and
Innovation, Ministry of Health, Wellington, New Zealand
United Nations Educational, Scientific and Cultural Organization
Irakli Khodeli, Programme Specialist, Social and Human Sciences Sector, UNESCO Jakarta Office
Jakarta, Indonesia. E-mail: [email protected]
21
Annex 2. Programme of the meeting
DAY 0 – Monday 21 October 2019
DAY 1 – Tuesday 22 October 2019
Venue Icon Room, Museum of New Zealand Te Papa Tongarewa, 55 Cable Street, Te Aro
09:00 – 10:15 Opening Ceremony Moderator: Neil Pickering
Notetaker: Clyde Smith
• Mihi (greeting) and karakia (10m)
• Welcome remarks (10m) by the Honourable Jenny Salesa, Associate Minister of Health, New Zealand
• Waiata (song) - Purea Nei e Te Hau
• Welcome remarks (5m) by Neil Pickering, Chair, National Ethics Advisory Committee, New Zealand
• Opening remarks (5m) by Irakli Khodeli, Programme Specialist, Social and Human Sciences Sector, United Nations
Education, Science and Cultural Organization (UNESCO) Jakarta Office, Indonesia
• Opening remarks (5m) by Tasnim Azim, Regional Advisor for Health Research Policy, World Health Organization
Regional Office for South East Asia Region (WHO SEARO), India
• Opening Remarks + Introductory Presentation: “The Role of Ethics in Reducing Health Inequities and Advancing
Universal Health Coverage” (15m) by Darryl Barrett, Coordinator for Health Law & Ethics, World Health
Organization Regional Office for the Western Pacific (WHO WPRO), Philippines
• Self-introductions of participants (15m)
• Meeting overview and administrative announcements by Nic Aagaard, Principal Advisor, Ethics, Ministry of
Health, New Zealand (5m)
• Group photo (5m)
10:15 – 10:45 Karakia mō te kai (Blessing the food) + Tea Break
Venue Ministry of Health, 133 Molesworth Street, Thorndon
Those attending the Meeting of the Steering Committee and Secretariat are kindly requested to
arrange their own transportation (e.g., taxi) to the Ministry of Health (expected travel time from QT
Hotel: 10m).
16:30 – 17:30 Meeting of the Steering Committee and Secretariat – invitation only (Meeting Room G.C.2)
17:30 Group shuttle from QT Hotel to Ministry of Health
18:00 – 20:00
Welcome Reception – all participants
• Welcome remarks by Ashley Bloomfield, Director General, Ministry of Health
• Refreshments
20:00 Group shuttle from Ministry of Health to QT Hotel
22
10:45 – 12:00 Session 1: Climate Change, Ethics, Equity
and Health
Moderator: Aarati Shah
Notetakers: Courtney Parnell, Margaret Earle
Climate change will affect health, both the requirements for health such as the provision of clean water and air as
well as the distribution of health impacts. Particular populations may be disproportionately affected by climate
change including outdoor workers, and those in coastal or low-lying riverine zones. A number of countries in the
region are among those with the highest level of long-term climate change risk.
Objectives:
- Provide an overview of the current status of climate change and health ethics in the region
- Discuss key health ethics issues and challenges facing the region in the context of climate change
- Identify health ethics solutions and strategies to reduce avoidable gaps in health status and health impact
between groups arising from climate change
• Technical presentation (20m): “Climate Change and Health Ethics” by Rhys Jones, Senior Lecturer in Måori
Health, University of Auckland; Co-convenor of Orataiao (New Zealand Climate and Health Council)
• Report (5m): “Results of Country Survey on Climate Change and Health Ethics in the Asia-Pacific Region” by Dena
Kirpalani, Consultant, Health Law & Ethics Unit, WHO WPRO
• Country Perspectives Panel
- Bangladesh (Mahmood Uz-Jahan): Research ethics and climate change - knowledge of research ethics among
doctors (5m)
- Nepal (Prakash Ghimire): Role of national organisations in climate change adaptation and mitigation (5m)
- Republic of Korea (Eun-Kyung Choi): Climate change-related strategic plan in Korea - inequities and privacy issues
(5m)
- Fiji (Eric Rafi): Public health ethics (5m)
• Plenary discussion (30m)
12:00 – 13:00 Group Work 1 Moderator: Rhys Jones
Notetakers: Courtney Parnell, Margaret Earle
• Parallel breakout sessions (30m)
Stream Facilitator Notetakers Venue
A: Clinical Ethics Mahmood Uz-Jahan Mark Joyce, Changgyo Yooon Angus Rooms
B: Public Health Ethics Dana Wesley Margaret Earle, Ki-Hyun Hahm Icon Room
C: Research Ethics Aarati Shah Hayley Roberton, Dena Kirpalani Blue Whale
• Report back + Plenary discussion (30m)
13:00 – 14:30 Karakia mō te kai (Blessing the food) + Lunch + Networking
23
14:30 – 16:00 Session 2: Emerging Technologies, Ethics, Equity and Health
Moderator: Bang-Ook Jun
Notetaker: Hayley Robertson
States’ abilities to manage bioethical challenges and to identify the ethical, legal and social implications of emerging
technologies and their application will affect health and impact the distribution of their health impacts. Countries in
the region are investigating how emerging technologies can be utilized to address needs whilst tackling the risks
associated with emerging technologies such as privacy, consent and inequity of access.
Objectives:
- Provide an overview of the current status of emerging technologies and health ethics in the region
- Discuss key health ethics issues and challenges facing the region in the context of emerging technologies
- Identify health ethics solutions and strategies to reduce avoidable gaps in health status and health impact
between groups arising from emerging technologies
• Technical presentation (20m): “People-centric Approaches to Ensure Equity in the Development of Ethical
Guidelines for Biomedical and Health Research in Emerging Technologies” by Roli Mathur, Scientist F & Head,
ICMR Bioethics Unit, National Centre for Disease Informatics & Research, Indian Council of Medical Research,
Department of Health Research, Ministry of Health and Family Welfare, India
• Report (5m): “Results of Country Survey on Emerging Technologies and Ethics in the Asia-Pacific Region” by
Dena Kirpalani, Consultant, Health Law & Ethics Unit, WHO WPRO
• Country Perspectives Panel - China (Xiaomei Zhai): Ethics of emerging technologies (5m) - Japan (Mika Shigematsu): Progress of bioethics issues for genome editing technology use on human
fertilised cell for research purposes (5m) - Mongolia (Enebish Oyunsuren): Equity and health technology (5m) - Singapore (Devanand Anantham): Pre-implantation genetic screening (5m) - Indonesia (Triono Soendoro): Ethics of emerging technologies (5m) - Vietnam (Quang Nguyen Ngo): Management of research on stem cell, cellular and gene therapy
products (5m) - Thailand (Yuthavong Yongyuth): Research ethics (5m) - Fiji (Eric Rafai): Research ethics (5m)
• Plenary discussion (25m)
16:00 – 17:00 Group Work 2 + Karakia mō te kai (Blessing the food) + Working Tea Break
Moderator: Roli Mathur
Notetaker: Hayley Robertson
• Parallel breakout sessions (30m)
Stream Facilitator Notetakers Venue
A: Clinical Ethics Lynley Anderson Martin Kennedy, Irakli Khodeli Angus Rooms
B: Public Health Ethics Bang-Ook Jun Kirsten Forrest, Darryl Barrett Icon Room
C: Research Ethics Mahmood Uz Jahan Mark Joyce, Tasnim Azim Blue Whale Room
• Report back + Plenary discussion (30m)
17:00 – 18:00 Free Time
24
18:30 – 19:00 Informal Reception
Venue Signs of a Nation, Museum of New Zealand Te Papa Tongarewa, 55 Cable Street, Te Aro
19:00 – 21:00 Karakia mō te kai (Blessing the food) + Welcome Dinner + Cultural Event
Venue Te Marae , Museum of New Zealand Te Papa Tongarewa, 55 Cable Street, Te Aro
DAY 2 – Wednesday 23 October 2019
Venue Icon Room, Museum of New Zealand Te Papa Tongarewa, 55 Cable Street, Te Aro
09:00 – 09:15
• Recap of Day 1 and Outlook for Day 2 by Nic Aagaard, Ministry of Health, New Zealand (5m)
• Reflections from the Chair (5m)
• Comments by Participants (5m)
09:15 – 10:30 Session 3: Indigenous Populations, Ethics, Equity and Health
Moderator: Mahmood Uz-Jahan
Notetaker: Margaret Earle
The health of indigenous persons can be impacted by their status as members of indigenous populations. Structural inequity shapes the health of indigenous peoples globally, and oft times deeply embedded in a history of individual and institutional racism, and inequitable social policies and practices, including the participation of indigenous persons in health-related research and public health campaigns. A number of countries and indigenous groups in the region are employing strategies for promoting equity in health care and research for indigenous populations.
Objectives:
- Provide an overview of the current status of indigenous populations and health ethics in the region - Discuss key health ethics issues and challenges facing the region in the context of emerging technologies - Identify health ethics solutions and strategies to reduce avoidable gaps in health status and health impact
between groups arising from emerging technologies
• Technical presentation (20m): “Supporting Equity in Health Ethics with Indigenous Populations: The Aotearoa New Zealand Experience” by Maui Hudson, Associate Professor, Faculty of Maori and Indigenous Studies, University of Waikato, New Zealand
• Report (5m): “Results of Country Survey on Indigenous Populations and Ethics in the Asia-Pacific Region” by Dena Kirpalani, Consultant, Health Law & Ethics Unit, WHO WPRO
• Country Perspectives Panel - Palau (Gaafar Sers Jose Uherbalau): Promoting ethics and reducing inequities in small island states (5m) - Philippines (Leonardo de Castro, Kathleen Grace Lentija): Mainstreaming health research involving
indigenous peoples (5m) - Cook Islands (Nuhisifa Seve-Williams): Injuries – research ethics (5m) - Cambodia (Chap Seak Chhay): How to address effectively the ethical issues in Cambodia? (5m) - Bhutan (Kinley Dorjee): Research ethics (5min) - Lao PDR (Latsamy Siengsounthone): Public health ethics (5m)
• Plenary discussion (20m)
25
10:30 – 11:30 Group Work 3 + Karakia mō te kai (Blessing the food) + Working Tea Break
Moderator: Maui Hudson
Notetaker: Margaret Earle
• Parallel breakout sessions (30m)
Stream Facilitator Notetakers Venue
A: Clinical Ethics Neil Pickering Kirsten Forrest, Changgyo Yoon Angus Rooms
B: Public Health Ethics Clyde Smith Hayley Robertson, Ki-Hyun Hahm Icon Room
C: Research Ethics Roli Mathur Rob McHawk, Dena Kirpalani Blue Whale Room
• Report back + Plenary discussion (30m)
11:30 – 13:00 Karakia mō te kai (Blessing the food) + Lunch + Networking
13:00 – 14:15 Session 4: Challenges and opportunities in strengthening national capacities for health ethics
Moderator: Neil Pickering
Notetaker: Rob McHawk
Strengthening national capacities for health ethics – including the respective capacities of national ethics/bioethics committees and their government counterparts, as well as the communication and coordination between them – is critical to ensure robust assessment of issues and offer empirically informed identification of ethical solutions and policy recommendations.
Objectives:
- Discuss challenges and opportunities for strengthening national capacities in the region, including support from UNESCO and WHO at the global, regional, and national levels
- Share experiences from countries in strengthening national capacities for health ethics
• Technical presentation (10m): “UNESCO support to countries in strengthening national capacities for health ethics” by Irakli Khodeli, Programme Specialist, Social and Human Sciences Sector, United Nations Education, Science and Cultural Organization (UNESCO) Jakarta Office, Indonesia
• Technical presentation (10m): “WHO support to countries in strengthening national capacities for health ethics” by Tasnim Azim, Regional Advisor for Health Research Policy, WHO SEARO, India + Ki-Hyun Hahm, Technical Officer for Health Law & Ethics, WHO WPRO, Philippines + Changgyo Yoon, Technical Officer, WHO Representative Office for the South Pacific, Fiji
• Country Perspectives Panel - Nepal (Prakash Ghimire): ERB process for FERCAP accreditation through WHO technical support (5m) - Solomon Islands (Freda Pitakaka): Strengthening health research system at the provincial level (5m) - India (Roli Mathur): Establishment/operationalization of national ethics committees (5m) - New Zealand (Nic Aagaard): National ethical standards for health research and quality improvement (5m) - Vietnam (Quang Nguyen Ngo): Circular on organisation, function and duty of ethics committees (5m) - Singapore (Richard Magnus): Incorporating BAC’s guidelines into Human Biomedical Research Act (5m) - Indonesia (Triono Soendoro): Legitimate Health Research by International Ethical Standard (5m) - Papua New Guinea (Maluo Magaru): PNG experience (5m)
• Plenary discussion (15m)
26
14:15 – 15:30 Session 5: Ways Forward + Working Tea Break
Moderators: Tasnim Azim + Darryl Barrett
Notetaker: Margaret Earle
Objectives:
- In subregional groupings, reflect on the issues discussed over the course of the meeting to identify common priority themes and emerging themes
- In country teams, draft country action plans to identify next steps towards strengthening national capacities for health ethics and reducing health inequities on priority issues through health ethics strategies and solutions
• Session Overview (5m)
• Parallel breakout sessions (30m)
Grouping Facilitator Notetakers
A: Bangladesh, Bhutan, Nepal Tasnim Azim Icon Room
B: Brunei Darussalam, Indonesia, Malaysia, Mongolia, Philippines
Irakli Khodeli Icon Room
C: Japan, Republic of Korea, New Zealand, Singapore Ki-Hyun Hahm Blue Whale
D. Cambodia, China, Lao PDR, Thailand, Viet Nam Darryl Barrett Angus Room
E. Cook Islands, Fiji, Palau, Papua New Guinea, Samoa, Solomon Islands
Changgyo Yoon Rangimarie Room
• Report back + Plenary discussion (30m)
• Round of closing remarks from WHO WPRO, WHO SEARO, UNESCO, Ministry of Health, Chair (10m)
27
Annex 3. Summary of Conclusions from participants’ group work
28
29
30
31
Annex 4. SESSION 5: WAYS FORWARD – COUNTRY WORKSHEETS
In sub-regional groupings, participants reflect on the issues discussed over the course of the meeting and considered common priorities and themes relevant to
their country context. They completed worksheets to identify potential next steps towards country planning in strengthening national capacities for health
ethics in line with the central theme of AP-NEC 2: reducing inequities through solutions-orientated bioethics. These are contained in this Annex in
alphabetical order.
32
BANGLADESH
Immediate e.g. One Week to 4 weeks after AP-NEC2
Short Term e.g. three (3) months after AP-NEC 2 (Jan 2020)
Medium – Long Term e.g. one year+ after AP-NEC 2 (October 2020)
What? What are the next steps to be taken within this time frame?
Intra official discussion and sharing the AP-NEC 2 outcomes with the members of the National Research Ethics Committee (NREC) The suggestion from findings of the meeting to go forward
Discussion meeting with relevant stakeholders regarding existing ethical guidelines, laws & legislation, way of policy implication Identifying the common challenges and opportunities and possible way of solution May arrange a discussion meeting/round table discussion Inclusion of recommendation from APNEC 2 in National Health Research Strategy
Arrange a national meeting IRB’s personal. Dissemination of National Ethical guideline and National Health Research Strategy in respect of country region Formation of Research Monitoring cell.
Who? Who are the key stakeholders?
NREC Members of NREC; policy makers from MOH&FW; representative from relevant ministries such as ministry of Environment, Ministry of disaster management and relief; Forest and Climate changes, representative from WHO section, representative from DGDA, DGDA, Professional bodies, Medical Education, relevant INGOs and NGOs
Members of NREC, Members from the respective ministries; representative from WHO section, Director General of DGHS, Director General of DGDA, president of professional bodies, Director from CME and representative from relevant INGOs and NGOs
Resources What is needed to accomplish these steps?
Documents on Ethics. Available resources on existing ethical guideline related to climate changes, emerging technologies and indigenous population Financing
Available existing guideline of medical ethics and research ethics of relevant topics Available country region information based on climate change, emerging technologies and indigenous population
Available guideline on ethics relevant with emerging technologies for distribution Available guideline on ethics relevant with Climate changes for distribution Available guideline on ethics relevant with indigenous population for distribution Feedback template Pen, paper, power point
Support What resources or support do you need from WHO/UNESCO?
Intellectual support such as clinical, public health and research ethics experts Financial support such as Honorium for resources persons & participants, refreshment for meeting attendance, and other associates to arrange a meeting,
Consultative support Intellectual support relevant with ethics experts Financial support for Training
Training-long term & short-term training on relevant topics Consultative meeting with representative of WHO/UNESCO before arranging the programme
• Sharing the updating knowledge and resources
• Intellectual support relevant with ethics experts
• Financial support
• Ongoing monitoring support for maintaining the quality of programme and implementing research work
33
Outcomes What are your desired outcomes?
Sensitization of NREC members. Increase awareness on relevant topics Identifying the priority areas accurately as per needs.
Update of existing Ethical guideline & SOP’s. Properly work distribution among stakeholders Outline of feedback mechanism Assist to policy makers and relevant stakeholders for initiation of next steps.
Implementation of Guideline properly Strengthening the capacity of NREC Strengthening the capacity build-up of Researcher, Reviewers
34
BHUTAN
Immediate e.g. One Week to 4 weeks after AP-NEC2
Short Term e.g. three (3) months after AP-NEC 2 (Jan 2020)
Medium – Long Term e.g. one year+ after AP-NEC 2 (October 2020)
What? What are the next steps to be taken within this time frame?
Sharing the issues discussed during the AP-NEC with the health research unit and other relevant stakeholder to incorporate the issues of climate change, emerging technology and indigenous people during the review
Website development for Research ethics board of health to improve data sharing and access to ethical review
Ensuring and strengthening the Health Technology Assessment guideline to include ethical component
Develop ethical framework and guidelines for data sharing
Who? Who are the key stakeholders?
REBH, Research unit and health management information unit
National environment commission, Ministry of agriculture and forests, ministry of health, Royal University of Bhutan, National referral hospital, policy and planning division Research ethics board of health, ICT division of health, health management and information unit, policy and planning division
Ministry of health, national environment commission, department of hydro-met services, ministry of economic affairs, ministry of agriculture and forests
Resources What is needed to accomplish these steps?
[No additional resources] Financial resource and technical support in developing the website; resources for the capacity building of the HTA panellist on ethics and health technology
[No additional resources]
Support What resources or support do you need from WHO/UNESCO?
[No additional support requested] Financial support for development of website and web management fee; Technical support for development of guideline
[No additional support requested]
Outcomes What are your desired outcomes?
Issues discussed and disseminated to all Website for REBH developed Ethics incorporated in HTA guideline
National data sharing framework
35
BRUNEI DARUSSALAM
Immediate e.g. One Week after AP-NEC2
Short Term e.g. three (3) months after AP-NEC 2 (Jan 2020)
Medium – Long Term e.g. one year+ after AP-NEC 2 (October 2020)
What? What are the next steps to be taken within this time frame?
Share meeting report together with recommendations with MOH, Brunei
Sharing of recommendations with stakeholders Setting up national research framework
Multi-sectoral discussion/s re national research framework established Drafting of policies/guidelines
Who? Who are the key stakeholders?
Ministry of Health MHREC IRB (University)
Ministry of Health MHREC IRB (University)
Ministry of Health Other ministries and government agencies- MHREC IRB (university)
Resources What is needed to accomplish these steps?
Documentation Funding (MOH) Technical assistance Funding
Support What resources or support do you need from WHO/UNESCO?
[No additional support requested] Research capacity building training and technical assistance to set up research framework
Technical assistance
Outcomes What are your desired outcomes?
Endorsement of recommendations from MOH Dialogue set up established Draft national research framework
National research framework established Policies/guidelines established
36
CAMBODIA
Immediate e.g. One Week to 4 weeks after AP-NEC2
Short Term e.g. three (3) months after AP-NEC 2 (Jan 2020)
Medium – Long Term e.g. one year+ after AP-NEC 2 (October 2020)
What? What are the next steps to be taken within this time frame?
Make report to chair of NECHR Capacity building Emerging technologies
Capacity building of NECHR involving human subjects, training and training of trainers Emerging technology Revise ethical guidelines and SOPs of the NECHR
Who? Who are the key stakeholders?
NECHR chair and members NECHR Researchers Policy makers Teachers Professors
NECHR (National Ethics Committee for Health Research) Researchers Policy-makers Teachers Professors
Resources What is needed to accomplish these steps?
Computer and electricity Finance and human resources / Funding and training
Financial and human resources Funding and training
Support What resources or support do you need from WHO/UNESCO?
All materials of conferences Technical and financial resources Technical and financial resources
Outcomes What are your desired outcomes?
Well-informed NECHR
Competent for NECHR and teachers and professors High quality standards of reviews Quality in teaching ethical practices for students
Competent for NECHR and for teachers/professors Up to date guidelines and SOPs High quality of reviews Quality in teaching ethical practices for students
37
CHINA
Immediate e.g. One Week to 4 weeks after AP-NEC2
Short Term e.g. three (3) months after AP-NEC 2 (Jan 2020)
Medium – Long Term e.g. one year+ after AP-NEC 2 (October 2020)
What? What are the next steps to be taken within this time frame?
Release an ethical Guideline on Clinical Research Make a plan for Training Program
Provide training courses in research ethics Initial supervision system
Implementation Start to check the quality via the system
Who? Who are the key stakeholders?
Policy-makers Professionals IRB members Trainers
Hospitals, doctors, researchers (both basic scientists and clinical researchers)
Strengthen the education program on bioethics at medical universities
Resources What is needed to accomplish these steps?
Bioethicists who have the knowledge about substantial ethics and have knowledge and capacity for reasoning and argument for special ethical issues. Not only do it via their tuition. WHO and UNESCO specialists.
Same as immediate term System and capacity building
Support What resources or support do you need from WHO/UNESCO?
Specialists on bioethics Specialists on bioethics Specialists on bioethics
Outcomes What are your desired outcomes?
Help scholars in China set up a unified ethical standard and guidelines according to international guidelines
Implementation (long term work) Implementation
38
COOK ISLANDS
Immediate e.g. One Week to 4 weeks after AP-NEC2
Short Term e.g. three (3) months after AP-NEC 2 (Jan 2020)
Medium – Long Term e.g. one year+ after AP-NEC 2 (October 2020)
What? What are the next steps to be taken within this time frame?
Write a report to MoH on meeting Write ethics guidelines for humans Set up ethics committees
Climate change on the national agenda Research priorities identified
Who? Who are the key stakeholders?
MoH MoH MoH
Resources What is needed to accomplish these steps?
Access to online materials Time to write Government buy-in
Government buy-in
Support What resources or support do you need from WHO/UNESCO?
Access to presentation materials Online materials
We need funding to support training of ethics committee and writing of ethical guidelines
Funding to support priorities, workshops and to support research
Outcomes What are your desired outcomes?
Completion of tasks Committee meets to review applications Research terminology is defined by Cook Islands understandings
Grassroots understanding of climate change research and research ethics
39
FIJI
Immediate e.g. One Week to 4 weeks after AP-NEC2
Short Term e.g. three (3) months after AP-NEC 2 (Jan 2020)
Medium – Long Term e.g. one year+ after AP-NEC 2 (October 2020)
What? What are the next steps to be taken within this time frame?
Provide feedback on climate change & health unit in the Ministry Provide feedback to Health Research Ethics reviewers and Ministry of Health executives Provide feedback to indigenous ministry of ethics committee
Development of interdisciplinary ethics committee; engage with climate change team on KPIs for the plan Conduct consultation with climate change and health unit on draft policy for research ethics Participate in indigenous research ethics committee and invite a representative from the indigenous ministry to be part of the health research committee
Work with FEMAT on EMT policy (expedited review) that governs all visiting EMT (incl. research teams for disasters) Engagement with national research council through an inter-disciplinary research committee Establishment of MoU with UNESCO and WHO on capacity building on research ethics committees
Who? Who are the key stakeholders?
Climate Change & Health Committee Ministry of Itaukei research ethics focal point National health researcher reviewer and committee
National health research committee reviewers and members Ministry of education and Ministry of Indigenous affairs focal points Other Pacific countries' ministries of health interested in strengthening bioethics
National disaster management office, FEMAT, National research council, WHO and UNESCO focal points, Ministry ESU, bioethics focal points of ministries of health of other countries
Resources What is needed to accomplish these steps?
Communication via email and on-line sharing of technical documents and survey report
Consultation workshop, face to face meetings and trainings
Policy development in peri-disaster period, Memorandum of Understanding with UN agencies
Support What resources or support do you need from WHO/UNESCO?
On-line resources e.g. dropbox link, complete results of the survey to share with the respective units
WHO technical assistance; workshop funding; contracted technical expertise
WHO and UNESCO technical contractors; training funds (3 years) and ethics committee members mentorship
Outcomes What are your desired outcomes?
Create awareness on the outcomes, outputs of the meeting and consensus on 'problems & solutions' on the three major themes of discussion
Establishment of an interdisciplinary ethics committee in government and the ministry of health
Strengthened capacity for bioethics committee with support of WHO and UNESCO for 3 years
40
INDIA
Immediate e.g. One Week to 4 weeks after AP-NEC2
Short Term e.g. three (3) months after AP-NEC 2 (Jan 2020)
Medium – Long Term e.g. one year+ after AP-NEC 2 (October 2020)
What? What are the next steps to be taken within this time frame?
Present the meeting report to ICMR Identify stakeholders for AI ethics and Tribal Populations Develop plan for ethics curriculum
Appoint subcommittees to draft ethical guidelines for research on tribal populations Plan the AI ethics consultation with experts including data scientists and civil society & others Appoint subcommittee to draft various sections for ethics curriculum for teaching at various levels students, researchers and ethics committees
Draft national guidelines for research on tribal groups Hold artificial intelligence expert consultation meeting meeting to finalize the ethics curriculum for India (researchers, ethics committee) regional meeting for SEA on ethics/ ethics training for SEA Region
Who? Who are the key stakeholders?
Ethics committee members, bioethicists, researchers, medical scientists working on AI, data scientists, members of civil society, scientists working with tribal groups, tribal population representatives
Ethics committee members, bioethicists, researchers, medical scientists working on AI, data scientists, members of civil society, scientists working with tribal groups, tribal population representatives
Ethics committee members, bioethicists, researchers, medical scientists working on AI, data scientists, members of civil society, scientists working with tribal groups, tribal population representatives
Resources What is needed to accomplish these steps?
[No additional resources] Budget for consultative meetings, budget for development of curriculum
AI consultative workshops/ meetings, ethics curriculum finalization meeting budget
Support What resources or support do you need from WHO/UNESCO?
[No additional support requested] WHO can support consultation for AI meetings and UNESCO can support ethics curriculum development
WHO can support consultation for AI meetings and ethics training for SEA region and UNESSCO can support ethics curriculum development
Outcomes What are your desired outcomes?
[None stated] Expert and public consultations and engagement to get feedback from various stakeholders
Finalization of a guidelines document and ethics curriculum
41
INDONESIA
Immediate e.g. One Week to 4 weeks after AP-NEC2
Short Term e.g. three (3) months after AP-NEC 2 (Jan 2020)
Medium – Long Term e.g. one year+ after AP-NEC 2 (October 2020)
What? What are the next steps to be taken within this time frame?
Make an evaluation/ research plan for strengthening NEC (National Ethics Commission of Ministry of Health) Develop instruments for accreditation for all IEC
Submit evaluation research proposal Prepare validity instruments for accreditation Continue training and supporting IEC/IRB
On-going research evaluation activities Pilot test evaluation for accreditation
Who? Who are the key stakeholders?
NEC, IEC, academic and hospital member NEC, IEC, academic and hospital member NEC, IEC, academic and hospital member
Resources What is needed to accomplish these steps?
Financial support Financial support Financial support; materials of bioethics/ climate change
Support What resources or support do you need from WHO/UNESCO?
[No additional support requested] Financial as well as technical support Financial as well as technical support
Outcomes What are your desired outcomes?
[None stated] Documents: proper design evaluation research Dissemination and publication
42
JAPAN
Immediate e.g. One Week to 4 weeks after AP-NEC2
Short Term e.g. three (3) months after AP-NEC 2 (Jan 2020)
Medium – Long Term e.g. one year+ after AP-NEC 2 (October 2020)
What? What are the next steps to be taken within this time frame?
Preparation of the Trip Report for the relevant directors and deputy-directors in the Cabinet Office. Preparation of the short-focused report of the meeting to share with relevant section of the MoH and MEXT. Preparation for the formal internal report included recommended action forward.
Provide official report to the Expert Panel for Bioethics, Council for Science, Technology and Innovation, Cabinet Office, Japan Preparation of the hand over material for the next AP-NEC logistics and an informative material for the Global Summit attendee. Frame work recommendation for assessment by IRB on research project using genome modification on human embryos from the Expert Panel for Bioethics to the Council for Science, Technology and Innovation may published (which currently under discussion).
Discussion of "bioethics governing", WHO is responsible for what bioethical topic and collaboration frame work for relevant Ministries by subjects. Or new idea of setting up the one independent NEC for all ethical issues if Government decides. Completion of the development or revision of the series of national guidelines for the basic and clinical researches using genome modification technology on human embryos. Including the guidance for the establishment of the system/structure for the research protocol and ELSI assessment in the country (expansion of IRB TOR, revision of IRB member requirements etc)
Who? Who are the key stakeholders?
Cabinet office senior managers, MoH and MEXT PI working with genome modification technologies, Medical facilities and Universities and research institutions where those PI affiliate, MEXT, MoH, society
PI working with genome modification technologies, Medical facilities and Universities and research institutions where those PI affiliate, MEXT, MoH, society
Resources What is needed to accomplish these steps?
My time and effort Time, summary report from the 2nd AP-NEC meeting
Not sure
Support What resources or support do you need from WHO/UNESCO?
Ideal if the official report for the meeting comes out in time to attached with some prospect on practical action the Region may able to take for the next step (sounded it is still at the level of each country effort to make).
[No additional supported requested] Support on providing IRB training may be of possibility if it could be done by mother tongue and if the Panel recommend to seek training to all IRB members in research entities (either to pose new "qualification" and/or modify current requirement is currently under discussion at the Expert Panel)., but it is after being decided the direction by the Panel.
Outcomes What are your desired outcomes?
Succeed to convince the importance to collaborate with regional countries working on bioethics issues will benefit to clarify the standard for the research bioethics practice for the emerging technology application, such as genome modification and AI in health.
Expert Panel recommendations Any conclusion will be accepted given it comes out from in-depth discussion by the Expert Panel for Bioethics. (Current suggestions for genome editing technology involved research include; 1) all assessment should be done at IRBs in the research facilities where PI belongs with additional
43
requirements to call in internal or external bioethics specialists on board, 2) 1+subject to the National Bioethics Board (newly establish technical committee?), 3) all to the National Committee, 4) or other)
44
REPUBLIC OF KOREA
Immediate e.g. One Week to 4 weeks after AP-NEC2
Short Term e.g. three (3) months after AP-NEC 2 (Jan 2020)
Medium – Long Term e.g. one year+ after AP-NEC 2 (October 2020)
What? What are the next steps to be taken within this time frame?
KPIs for cross-sectoral action Collect ethnicity data
NECs should develop a lot of ethics preparedness and review protocols Increased interaction and coordination between NECs and other research oversight bodies & public health authorities Identification of risk, lack of clinical research expertise, early roll out Decentralization and diversification of research, blurring line between clinical application and quality, public health Knowledge gap between researchers and others (public, government, NECs) is widening, research literacy and understanding of state of current technology is limited
Climate change ethics to global level for leadership Develop ethical framework for data sharing internationally Ensure adequate treatment facilities, financing, national bodies need to intervene Number, complexity and pace of new technologies is outpacing ethical guidelines/ law Increased global inequity through improving health of some but not all Influence of industry and politics including technology introduced but not licenced in country
Who? Who are the key stakeholders?
Ministry of Health
National Ethics Committees, Ministries of Health, Academic Societies Researchers, public practitioners, policy-maker, national bioethics committee, public
Academics –Medical School/ UPNG Institute of Medical Research
Resources What is needed to accomplish these steps?
Political resources
Conference, media
Human resources, financial resources Law enforcement, building guidelines
Support What resources or support do you need from WHO/UNESCO?
[No additional support requested] Examples from other countries
Global ethical and legal frameworks
Outcomes What are your desired outcomes?
Developing climate-action leadership in healthcare
NEC-initiated protocols regarding climate change preparedness Building reliable, safe and efficacy of the emerging technology Building mutual understanding in the various stakeholders
Ethical framework for data sharing Narrowing the divide between technology, ethics and law
45
MALAYSIA
Immediate e.g. One Week to 4 weeks after AP-NEC2
Short Term e.g. three (3) months after AP-NEC 2 (Jan 2020)
Medium – Long Term e.g. one year+ after AP-NEC 2 (October 2020)
What? What are the next steps to be taken within this time frame?
National Ethics Committee Bring together all ethics committee under one platform To get political and administrator buy-in
Regular training of Ethical members Increased interaction and coordination between NECs and other research oversight bodies & public health authorities
National Guideline on Research in Malaysia Strengthen the Compliance Audit on Research approved in Malaysia
Who? Who are the key stakeholders?
Ministry of Health Ministry of Education, and other related Ministries
Ministry of Health Ministry of Education
Ministry of Health NERCIM Ministry of Education
Resources What is needed to accomplish these steps?
Human resource Funding Human Resource
Funding Human Resource for capacity building
Support What resources or support do you need from WHO/UNESCO?
WHO/UNESCO Ministry of health Registration of NERCIM (Network of Research Committee in Malaysia)
WHO/UNESCO Ministry of Health NERCIM National Ethics committee
Outcomes What are your desired outcomes?
National Ethics Committee NERCIM
ETTC training done Guideline on Research in Malaysia Regular compliance audit done
46
MONGOLIA
Immediate e.g. One Week to 4 weeks after AP-NEC2
Short Term e.g. three (3) months after AP-NEC 2 (Jan 2020)
Medium – Long Term e.g. one year+ after AP-NEC 2 (October 2020)
What? What are the next steps to be taken within this time frame?
National Ethics Committee Bring together all ethics committee under one platform To get political and administrator buy-in
Regular training of Ethical members Increased interaction and coordination between NECs and other research oversight bodies & public health authorities
National Guideline on Research in Malaysia Strengthen the Compliance Audit on Research approved in Malaysia
Who? Who are the key stakeholders?
Ministry of Health Ministry of Education, and other related Ministries
Ministry of Health Ministry of Education
Ministry of Health NERCIM Ministry of Education
Resources What is needed to accomplish these steps?
Human resource Funding Human Resource
Funding Human Resource for capacity building
Support What resources or support do you need from WHO/UNESCO?
WHO/UNESCO Ministry of health Registration of NERCIM (Network of Research Committee in Malaysia)
WHO/UNESCO Ministry of Health NERCIM National Ethics committee
Outcomes What are your desired outcomes?
National Ethics Committee NERCIM
ETTC training done Guideline on Research in Malaysia Regular compliance audit done
47
NEPAL
Immediate e.g. One Week to 4 weeks after AP-NEC2
Short Term e.g. three (3) months after AP-NEC 2 (Jan 2020)
Medium – Long Term e.g. one year+ after AP-NEC 2 (October 2020)
What? What are the next steps to be taken within this time frame?
Dissemination of the meeting presentations and report to NHRC/MOHP/Nepal
Interaction/consultation with responsible agencies in climate change, indigenous population and emerging technologies Review and revise the specific Guideline/SOP's Initiate process for Capacity building training
Finalization of the revision of Guideline/SOP Initiate Implementation of the project as per revised guideline/SOP Capacity building Trainings on ethical conduct of research, review & assessment of research protocols, monitoring of the ethical practice in research
Who? Who are the key stakeholders?
Prof Dr Prakash Ghimire, & Prof Dr Aarati Khanal Shah
ERB/NHRC/MOHP/ICMR/WH MOHP/GON/ICMR/WHO
Resources What is needed to accomplish these steps?
Meeting logistic Consultative meetings & Training plan Consultative workshops and Training
Support What resources or support do you need from WHO/UNESCO?
NHRC NHRC/WHO/UNESCO NHRC/WHO/UNESCO
Outcomes What are your desired outcomes?
Updates on health research /bioethics progress and challenges in the Asia and pacific (country & region)
Discussion and feedback from the AP-NEC meeting with the country responsible officials on good practices and opportunities. Initiation of process for capacity building collaboration
Finalization of the Guideline, SOP and Capacity building trainings
48
NEW ZEALAND
Immediate e.g. One Week to 4 weeks after AP-NEC2
Short Term e.g. three (3) months after AP-NEC 2 (Jan 2020)
Medium – Long Term e.g. one year+ after AP-NEC 2 (October 2020)
What? What are the next steps to be taken within this time frame?
Brief the Ministry of Health, NEAC and interested collaborators on APNEC II findings and topics. Review Pacific contacts from APNEC and liaise with Ministry of Foreign Affairs on developing a training program for research ethics.
Set work program for 2020, addressing need to strengthen clinical ethics infrastructure in relation to emerging technologies (AI), and in public health – gene editing. Scan current NZ work on ethics of climate change, noting recent climate bill was passed. Conduct training for all researchers and ethics committees on new ethical standards for research, focusing on indigenous populations ethics.
Support the Ministry of Health in revising the NZ Ethics Landscape, reviewing the scope of ethical review of national ethics committees. Support the Minister in developing gene editing in health / NZ. Review impact of ethical standards for research work and seek international engagement in assisting pacific countries with their standards.
Who? Who are the key stakeholders?
Bioethics committees, Ministry of Health, MFAT, Minister of Health
District health boards, Ministry, Health and Safety Quality Commission, Health Research Council, National Ethics Committees, other GOVT agencies.
District health boards, Ministry, Health and Safety Quality Commission, Health Research Council, National Ethics Committees, other GOVT agencies.
Resources What is needed to accomplish these steps?
Guidance on training ethics in other countries.
Expert advice from technical advisors on new technologies and climate change.
Expert advice from technical advisors on new technologies and climate change.
Support What resources or support do you need from WHO/UNESCO?
Advice and guidance on how to assist other countries with bioethics capacity
Share work and experience on emerging tech and gene editing from WHO and UNESCO international committees.
[No additional support requested]
Outcomes What are your desired outcomes?
Strengthen relationships with pacific neighbours, increase value and impact of NZ ethics work, share knowledge and build inter-govt and civil society relationships
Build relationships with WHO and UNESCO to advance NZ as a regional leader in bioethics. Build NZ capacity in clinical ethics.
Strengthen ethics environment, normalize ethics in govt work.
49
PALAU
Immediate e.g. One Week to 4 weeks after AP-NEC2
Short Term e.g. three (3) months after AP-NEC 2 (Jan 2020)
Medium – Long Term e.g. one year+ after AP-NEC 2 (October 2020)
What? What are the next steps to be taken within this time frame?
Review all Conference materials to identify what can be utilized by the Palau IRB with its development. Contact fellow colleagues from the Pacific region to initiate/continue dialogue on potential partnership and networking. Prepare report for Palau IRB board members on the findings/results of the 2nd AP-NEC Conference.
Proceed with Palau IRB proposed calendar of events and tasks as assigned by the IRB Board. Review and approve proposed IRB protocols; regulations; and fees, as developed by local consultant. Identify potential archiving system/database/repository system for Palau IRB to archive protocols and study results.
Conduct process evaluation on Palau IRB protocols and regulations as developed and approved by IRB Board.
Who? Who are the key stakeholders?
Palau IRB Secretariat (Gaafar Uherbelau, Health Policy, Research & Development Office); Palau IRB Board members; Other Pacific Island delegates who attended the 2nd AP-NEC Conference.
Palau IRB Board; Palau IRB Secretariat; Consultant (local)
Palau IRB Board; Palau IRB Secretariat
Resources What is needed to accomplish these steps?
AP-NEC2 Dropbox shared files; Time & Date coordination for zoom/conference calls.
Request for proposal for local consultancy on IRB regulation development.
External entity/ethics committee expertise
Support What resources or support do you need from WHO/UNESCO?
WPRO/WHO Suva to assist in forming a Pacific sub-regional group for information and best practices sharing amongst Pacific Island states
Assist Palau IRB Secretariat to identify suitable archiving/data repository system to be used to archive protocols and research data and results.
Identify potential external evaluator to review Palau IRB protocols and regulations.
Outcomes What are your desired outcomes?
Summary of relevant conference documents and findings to present to Palau IRB Board members; Initiate dialogue on potential regional partnerships on NEC/IRB development.
Reviewed and endorsed Palau IRB regulations and protocols; List create for IRB Board review of potential archiving systems that Palau IRB could utilize.
Enhanced Palau IRB regulations and protocols.
50
PAPUA NEW GUINEA
Immediate e.g. One Week after AP-NEC2
Short Term e.g. three (3) months after AP-NEC 2 (Jan 2020)
Medium – Long Term e.g. one year+ after AP-NEC 2 (October 2020)
What? What are the next steps to be taken within this time frame?
Compiling the workshop report and dissemination
Consultative meet with Climate Change team and Medical Research Advisory Committee
Consultative meetings/Country workshop/ Attend Portugal and Nepal next Ethics/Bio Ethics meeting
Who? Who are the key stakeholders?
Public Health Team Clinical Chiefs/Medical Standards Team
Climate Change team/Medical Research Advisory Committee Line Departments
Senior Executive Management Public Health and Medical Standards Team Academics –Medical School/ UPNG Institute of Medical Research
Resources What is needed to accomplish these steps?
Workshop material/Presentation Climate Change literatures/Policies and Strategies. Country meeting reports
Financial Support/Materials of Bio-ethics/Climate Change
Support What resources or support do you need from WHO/UNESCO?
Workshop session materials from the meeting in New Zealand
Ethics consultants Financial Support/ Ethics Consultant from the region
Outcomes What are your desired outcomes?
Workshop report completed, presented and disseminated
Committees established with TORs Policies and Strategies established Workshops conducted in country and Present country brief in next meeting
51
PHILIPPINES
Immediate e.g. One Week after AP-NEC2
Short Term e.g. three (3) months after AP-NEC 2 (Jan 2020)
Medium – Long Term e.g. one year+ after AP-NEC 2 (October 2020)
What? What are the next steps to be taken within this time frame?
Provide feedback to the respective agencies/offices what have transpired during the meeting Mapping out of existing Ethics Committees from different agencies, offices (internal)
Establish and strengthen networking among the stakeholders and internal key actors (DENR) and other existing Ethics Committees Plan joint capacity building
Capacity building/workshops/bench marking
Who? Who are the key stakeholders?
DOH PHREB
DOH PHREB WHO UNESCO Other partner agencies Asia-Pacific Country
DOH PHREB WHO UNESCO Other partner agencies Asia-Pacific Country
Resources What is needed to accomplish these steps?
[No additional resources] [No additional resources] Budget allocation if not sponsored
Support What resources or support do you need from WHO/UNESCO?
[No additional support requested] [No additional support requested] Experts from WHO/UNESCO
Outcomes What are your desired outcomes?
To ensure proper dissemination of information of what have transpired and recommended during the meeting
Timetable for plan of activities To be included in the lists of ethics committees with corresponding representation from their respective agencies/office as part of networking
Capacitated Ethics Committee Members and Secretariat Developed policies/guidelines to serve as a basis for strengthened regulation for proper implementation Shared information and updates for Ethical issues
52
SAMOA
Immediate e.g. One Week after AP-NEC2
Short Term e.g. three (3) months after AP-NEC 2 (Jan 2020)
Medium – Long Term e.g. one year+ after AP-NEC 2 (October 2020)
What? What are the next steps to be taken within this time frame?
Meet the chair of the Health Research Committee (HRC) to discuss about this meeting and its outcomes including recommendations. Present findings from this meeting to the HRC
Review HRC policy Meet or consult with other relevant ministries, stakeholders including Universities to discuss about the formation of a National Ethics/Bioethics Advisory Committee
Follow up on the formation of a "National Ethics/ Bioethics Advisory Committee" Request for capacity building training /workshop for HRC and National Ethics/ Bioethics Advisory Committee Create a National Ethics Committee that looks after ethics of all areas, especially with respect to research, health, climate change etc.
Who? Who are the key stakeholders?
Chair of HRC, who is also the Director General, and health research committee members
Ministry of Health and Councils regulated under the MoH (e.g. medical, dental, pharmacy etc.) Health related NGOs, Ministry of Environment and other relevant ministries and donor partners such as WHO and UNESCO
Ministries and relevant ministers, and their stakeholders, donor partners (WHO, UNESCO, MFAT, DFAT etc.)
Resources What is needed to accomplish these steps?
None None
Technical assistance on 'ethics' and funds
Support What resources or support do you need from WHO/UNESCO?
[No additional support requested] Technical assistance with the review of existing polities and/or consultations
Technical assistance and to advocate from the global and regional level for 'bioethics'
Outcomes What are your desired outcomes?
To receive support or blessing from the chair and HRC to support the development intended to improve the role of the HRC and introduce collaboration with other ministries or institutions that also regulate ethics and research, use of new technologies, monitor climate change and health
To update the HRC policy and to ensure the formation of a national body to oversee, monitor and regulate standards and ethics with regards to research, new technologies, climate change and other important values that influence and affect human (people) and health
To ensure the formation of a national body to oversee, monitor and regulate standards and ethics with regards to research, new technologies, climate change, equity and other things that will become important to use in the future
53
SINGAPORE
Immediate e.g. One Week after AP-NEC2
Short Term e.g. three (3) months after AP-NEC 2 (Jan 2020)
Medium – Long Term e.g. one year+ after AP-NEC 2 (October 2020)
What? What are the next steps to be taken within this time frame?
Identify and prioritise new emerging technologies we want to consider examining
[None stated] Partnerships with neighbour governments on bioethics and clinical ethics issues, capability and capacity Exhibitions to build public awareness of medical and bioethics / equity issues Collaboration with WHO and UNESCO to develop medical ethics and bioethics capability / initiatives
Who? Who are the key stakeholders?
[None stated] Legal profession, clinicians, scientists, youth groups, students, IRBs, religious groups
[None stated]
Resources What is needed to accomplish these steps?
Partnerships [No additional resources] Ethics Research
Support What resources or support do you need from WHO/UNESCO?
UNESCO /WHO- tapping into the experts [No additional support requested] Build a national ethics network for education and practice
Outcomes What are your desired outcomes?
[None stated] Competency, capacity, capability Regional Centre of Excellence for Medical ethics and Bioethics
54
SOLOMON ISLANDS
Immediate e.g. One Week after AP-NEC2
Short Term e.g. three (3) months after AP-NEC 2 (Jan 2020)
Medium – Long Term e.g. one year+ after AP-NEC 2 (October 2020)
What? What are the next steps to be taken within this time frame?
Draft and present a meeting report with recommendations to the Ministry of Health and WHO Office in Honiara Individual consultations with the Ministry of Health & WHO to gain support & their perspectives on the short-term-medium & long-term plans Finalizing recommendations for submission & endorsement to the Ministry of Health for WHO final review & endorsement
WHO to finalize contract with James Cook University to facilitate the second cohort of Research Capacity Building fellows WHO to review & finalize consultancy contract for the review of the Solomon Islands National Health Research Policy & the Operational manual for the Solomon Islands Health Research Ethics & Review Board (SIHRERB) in 2020 as per the Research Department Annual Operational Plan Formalize external /south-south institutional partnership for ongoing MHMS research & ethics capacity building
To facilitate the Research Capacity Building workshop for the second cohort of MHMS staff To develop operational tools (guidelines, ToRs) for the establishment of provincial level research hub To strengthen the National research ethics system by establishing electronic database for ethics
Who? Who are the key stakeholders?
Solomon Islands (SI) Ministry of Health & WHO country Office
SI Ministry of Health, WHO Country Office, James Cook University, Solomon Islands National University & WPRO Research Office
SI Ministry of Health, WHO Country Office, James Cook University & Solomon Islands National University
Resources What is needed to accomplish these steps?
Human resources, including Technical Time & Human Resources, including technical & funding support
Time & human resources, including technical & funding support
Support What resources or support do you need from WHO/UNESCO?
Technical Technical & Funding Support Technical & Funding Support
Outcomes What are your desired outcomes?
To obtain support from stakeholders in order to move on to the next phase of having the short-term plans achievable
To formalize agreements & support for the set of short-term plans
To train 20 local research fellows To establish 3 research hubs in 3 selected highly researched provinces Establish an electronic database with all 8 ethics members attended at least an ethics training annually in their two years of membership
55
THAILAND
Immediate e.g. One Week after AP-NEC2
Short Term e.g. three (3) months after AP-NEC 2 (Jan 2020)
Medium – Long Term e.g. one year+ after AP-NEC 2 (October 2020)
What? What are the next steps to be taken within this time frame?
Notify National committee Submit agenda for reducing inequities
Country draft plan on reducing inequities through solutions orientated bioethics
Final plan submitted to national economic and social development board of relevant bodies
Who? Who are the key stakeholders?
People's groups and civil societies, government agencies, private sector
People's groups and civil societies, government agencies, private sector
People's groups and civil societies, government agencies, private sector
Resources What is needed to accomplish these steps?
None
Budget from Ministry of Higher Education, Science, Research and Innovation (MHESI)
Budget from Ministry of Higher Education, Science, Research and Innovation (MHESI)
Support What resources or support do you need from WHO/UNESCO?
None Short term consultant
Short term consultant Training
Outcomes What are your desired outcomes?
Approval of proposal by National Committee for Promotion of ethics of Science and Technology
Approval by National Committee and MHESI
Approval by National Economic Social Development Board & Relevant Bodies Funding of programmes
56
VIET NAM
Immediate e.g. One Week after AP-NEC2
Short Term e.g. three (3) months after AP-NEC 2 (Jan 2020)
Medium – Long Term e.g. one year+ after AP-NEC 2 (October 2020)
What? What are the next steps to be taken within this time frame?
Disseminate the content of the course to researchers, ethic committee members, authorities
Develop guidelines for reducing inequities through solutions-orientated bioethics Develop a training programme for researcher on equity and efficacy in health research Develop a training programme for ethic committee member on equity and efficacy in reviewing and assessing health research.
Complete the legal framework for bioethics Strengthen the capacity of ethic committees Improve the capacity of researchers in bioethics research
Who? Who are the key stakeholders?
Ethic committee members, researchers, authority Ethic committee members, researchers, authority, sponsor
Ethic committee members, researchers, authority, sponsor, research sites/hospitals
Resources What is needed to accomplish these steps?
Literature review, disseminate meeting, website of national ethic committee
Technical support, workshops for contributing opinions
Project on strengthening national capacities for health ethics, focus on reducing inequities through solutions-orientated bioethics
Support What resources or support do you need from WHO/UNESCO?
Related documents International consultants, workshops, study visit for ethic committee members and ministry of health officers
Technical and financial support for the above project
Outcomes What are your desired outcomes?
All key stakeholders understand well the content of the course, especially the content of inequities in bioethics research.
A guideline for reducing inequities has been approved and disseminated by Ministry of Health and an advanced training programme on health ethics, focus on reducing inequities for researchers and for ethic committee members has been developed
Complete the national system for health ethics
57
www.wpro.who.int
Meeting Report